Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Biocept Inc

TRADE

NASDAQ: BIOCHealthcare / Medical Laboratories & Research / USA
6.22-0.26-4.01%Vol 234 5621Y Perf -85.69%
Jul 20th, 2018 16:00
BID6.21 ASK6.28
Open6.50 Previous Close6.48
Pre-Market6.01 After-Trading6.22
 -0.47 -7.25%  - -%
Target Price
19.52 
Analyst Rating
Moderate Buy 2.00
Potencial %
213.83 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★     52.92
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)14 
Earnings Rating
Buy
Price Range Ratio 52wk %
6.63 
Earnings Date
9th Aug 2018

Today's Price Range

6.006.50

 

52wk Range

3.5044.55

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
2 604.35%
3 Months
2 491.67%
6 Months
828.36%
1 Year
-85.69%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
BIOC6.22-0.2600-4.01
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.40
Long Term Debt to Total Capital 0.12
Total Debt to Equity 0.27
Interest Coverage -136.60
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-130.20
EBIT Margin-550.90
EBITDA Margin-535.70
Pre-tax Profit Margin-4 508.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.92
PS Ratios 5.61
Price to Cash Flow -
Price to Free Cash Flow -1.00
Cash Flow Per Share -17.77
Price to Tangible Book1.92
Book Value per Share3.74
Enterprise Value (in ths.)9 354
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)383.86
ROE last 12 Months -248.73
Return on Assets (5Y Avg) -100.44
ROA last 12 Months -144.04
Return on Capital (5Y Avg) -
ROC last 12 Months -194.95
Return on invested Capital Q -84.73
Return on invested Capital Y-492.25
Assets Turnover0.10
Receivables Turnover1.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 914
Revenue per Share 1.28
Revenue Growth 3 Years 131.22
Revenue Growth 5 Years 125.18
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-2.10-3.30-57.14
Q04 2017-5.71-5.415.25
Q03 2017-5.71-6.01-5.25
Q02 2017-6.01-6.31-4.99
Q01 2017-6.61-6.314.54
Q04 2016-0.34-0.2720.59
Q03 2016-0.57-0.570.00
Q02 2016-0.66-0.609.09
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.1178.43Positive
9/2018 QR-0.0884.91Positive
12/2018 FY-0.30--
12/2019 FY-0.18--
Next Report Date9th Aug 2018
Estimated EPS Next Report-3.30
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume234 562
Shares Outstanding (in ths.)2 270
Trades Count533
Dollar Volume1 368 480
Avg. Volume243 475
Avg. Weekly Volume636 655
Avg. Monthly Volume1 287 665
Avg. Quarterly Volume438 699

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%63%

Bearish Bullish

68%32%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Strong Buy
1.00

There are no comments yet.

News

x